Papers
25
Total Citations
1,460
H-Index
11
About
Christopher Weight is a urologic surgeon and clinical researcher whose work has fundamentally shaped the evidence base for robotic surgery in urological oncology. Best known as a principal investigator of the landmark RAZOR trial — a randomized, phase 3 study comparing robot-assisted and open radical cystectomy for bladder cancer — Weight helped establish that robotic approaches are non-inferior to traditional open surgery, a finding that has accumulated over 760 citations and influenced surgical practice worldwide. His subsequent three-year follow-up analysis further validated these conclusions by demonstrating durable oncologic outcomes across both techniques. Beyond bladder cancer, Weight has made significant contributions to understanding robotic surgery's role in prostate and kidney cancer care, including investigations into socioeconomic disparities in access to robotic surgical centers and the cost implications of robotic radical prostatectomy. His systematic reviews and meta-analyses on partial versus radical nephrectomy have similarly informed nephron-sparing surgical decisions. More recently, his work has expanded into public perception of artificial intelligence in medicine and pioneering single-port robotic techniques for prostate cancer. Collectively, Weight's research bridges rigorous clinical trial design with health policy and emerging technology, making him a consequential voice in modern minimally invasive urologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Public Perceptions of Artificial Intelligence and Robotics in Medicine98 citations · 2020
- 5
- 6
- 7
- 8
- 9
- 10Comparison of Robotic vs Open Cystectomy: A Systematic Review12 citations · 2023